InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Rhode Peter, Dirigeant. Officer active across 1 companies, notably HCW Biologics Inc.. Aggregated, 4 filings have been recorded. Total volume traded: €170k. The latest transaction was disclosed on 14 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€3141,714 shares@ €0.18330.0038% mcap0.4% of flow
Common Stock
SEC:0001209191-22-003785·
€3141,714 shares@ €0.18330.0038% mcap0.2% of flow
Common Stock
SEC:0001209191-22-003785:0·
€84,94212,500 shares@ €6.79541.03% mcap99.6% of flow
Common Stock
SEC:0001209191-21-048082·
Ideal exit: 18 Apr 2022 (T+270)
€84,94212,500 shares@ €6.79541.03% mcap49.8% of flow
Common Stock
SEC:0001209191-21-048082:0·
Ideal exit: 18 Apr 2022 (T+270)
4 of 4 declarations
About Rhode Peter
Peter Rhode is an Executive at HCW Biologics Inc. While his specific role is not detailed, he contributes to the leadership and management of the company's operations. Peter is involved in making strategic decisions that influence the organization's performance and growth. His expertise is essential for the development of the company's initiatives.
